Last reviewed · How we verify

Eligard (TM) — Competitive Intelligence Brief

Eligard (TM) (Eligard (TM)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GnRH agonist. Area: Oncology.

marketed GnRH agonist GnRH receptor Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Eligard (TM) (Eligard (TM)) — Chesapeake Urology Research Associates. Eligard is a leuprolide acetate depot injection that suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to reduced testosterone production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Eligard (TM) TARGET Eligard (TM) Chesapeake Urology Research Associates marketed GnRH agonist GnRH receptor
Lupron leuprorelin Accord Healthcare S.L.U. marketed Gonadotropin Releasing Hormone Receptor Agonist GnRH receptors 1985-01-01
Micronor norethisterone Johnson & Johnson marketed Progestin GnRH receptors 1962-01-01
TRIPTORELIN ACETATE, hCG TRIPTORELIN ACETATE, hCG HaEmek Medical Center, Israel marketed GnRH agonist GnRH receptor
triptorelin 0.1 triptorelin 0.1 Chong Qing Reproducive and Genetic Institute marketed GnRH agonist GnRH receptor
Ultra-Long GnRH Agonists Ultra-Long GnRH Agonists University of Palermo marketed GnRH agonist GnRH receptor
Triptorelin (GnRH agonists) Triptorelin (GnRH agonists) University of Pisa marketed GnRH agonist GnRH receptor (GNRHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (GnRH agonist class)

  1. Takeda · 4 drugs in this class
  2. Abbott · 3 drugs in this class
  3. Ipsen · 3 drugs in this class
  4. Changchun GeneScience Pharmaceutical Co., Ltd. · 3 drugs in this class
  5. University of Pisa · 2 drugs in this class
  6. Chong Qing Reproducive and Genetic Institute · 1 drug in this class
  7. Chesapeake Urology Research Associates · 1 drug in this class
  8. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
  9. Enteris BioPharma Inc. · 1 drug in this class
  10. Colorado Center for Reproductive Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Eligard (TM) — Competitive Intelligence Brief. https://druglandscape.com/ci/eligard-tm. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: